i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
You will also receive monthly ETF model portfolio and trend trader model portfolio
Two Week FREE Trial
Terms and Conditions
Exelixis, Inc. (NASDAQ: EXEL)
Current Price :
52 Week Low
52 Week High
Opinion and Analysis
Exelixis (EXEL): FDA OKs Cometriq for Thyroid Cancer Treatment
Nov 30, 2012 01:11 PM |
4 Biotech Stocks Ready To Explode
Sep 06, 2012 03:48 PM |
Comeback In The Afternoon
Jul 02, 2012 06:26 PM |
More Articles on EXEL..
Exelixis' Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma
Dec 15, 2014 01:00 AM |
Exelixis Announces Results from the COMET-2 Pivotal Phase 3 Trial of Cabozantinib in Men With Metastatic Castration-Resistant Prostate Cancer
Dec 01, 2014 08:00 AM |
Exelixis to Present at the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2
Nov 25, 2014 04:05 PM |
More Press Releases on EXEL..
Avg. Short Term
Avg. Long Term
Compare to S&P
Join Blog Network
| Copyright 2014 all rights reserved
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
. Advertisement partners
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.